Search Results for: ted talk

The valley of death: stem cells, biotechs, and money

For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically designed to get in the near future to a Phase

The valley of death: stem cells, biotechs, and money Read More »

Get a life!

One of the commenters on this blog told me, in response to my post on the opponents of stem cell research, to “get a life.” What’s a “life” according to this guy? To me? To you? We all lead different lives and have different ideas about what is a valuable life. We all face different

Get a life! Read More »

Clinical Trials Part II: Viacyte Director of Stem Cell Research Dr. D’Amour speaking today in Seattle

Dr. Kevin D’Amour, Director of Stem Cell Research at Viacyte, gave an excellent, extremely interesting talk Friday morning: Developing an Encapsulated Stem Cell Therapy for Diabetes. In the talk, Dr. D’Amour gave a very detailed description of their products Pro-Islet and Encaptra. Together these products form an encapsulated beta-cell product that is in pre-clinical development

Clinical Trials Part II: Viacyte Director of Stem Cell Research Dr. D’Amour speaking today in Seattle Read More »

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle

This morning there was a fantastic session here at the ASGCT meeting in Seattle on Clinical Trials on Stem Cells. One of the speakers was Geron VP, Jane Lebkoswki, PhD: Development of Human Embryonic Stem Cell-Based Therapies for Treatment of Human Degenerative Diseases. The talk was focused on OPC1 for the treatment of spinal cord

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle Read More »

News on iPS cells from some top scientists at ASGCT meeting today

There were three talks today on iPS cells here at the American Society for Gene and Cell Therapy in Seattle. Dr. James Ellis made the interesting case that it may actually be preferable to make iPS cells using genetic methods (while everyone else seems to be saying that non-genetic methods will be better). Dr. Ellis

News on iPS cells from some top scientists at ASGCT meeting today Read More »

Why invest in stem cells? Progress, Patients, and Patents

Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of patients. But there is another

Why invest in stem cells? Progress, Patients, and Patents Read More »

Who’s who in iPS cells: scientists, journals, funding agencies, countries, and biotechs

Who’s who in the iPS cell field?  In this post, I examine the people, journals, places, funding agencies, and companies that are the leaders in the iPS cell field. I start with publishing. Last year we did a post on publishing trends in the iPS cell field.  It suggested that the iPS cell field was exploding

Who’s who in iPS cells: scientists, journals, funding agencies, countries, and biotechs Read More »